• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管或食管胃交界腺癌患者中Barrett食管的患病率及特征

Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.

作者信息

Hamilton S R, Smith R R, Cameron J L

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

出版信息

Hum Pathol. 1988 Aug;19(8):942-8. doi: 10.1016/s0046-8177(88)80010-8.

DOI:10.1016/s0046-8177(88)80010-8
PMID:3402983
Abstract

The prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction are uncertain. We studied 61 consecutive esophagogastrectomy specimens with adenocarcinoma, which were subjected to extensive histopathologic examination. Barrett esophagus was found in 64% of the cases (39 of 61), but had been recognized in only 38% of the patients with Barrett-associated carcinoma who had undergone preoperative endoscopy with biopsy (13 of 34). The median extent of Barrett esophagus with adenocarcinoma was 5 cm (range, 1 cm to 12 cm), and distinctive-type ("specialized") Barrett mucosa predominated (35 of 39; 90%). The Barrett adenocarcinomas were centered in the distal esophagus 2 cm +/- 0.3 cm above the esophagogastric junction. The patients with Barrett adenocarcinoma showed a striking predominance of white men (34 of 39; 87%) in contrast to gastric adenocarcinoma cases (21 of 69; 30%) and to Barrett patients without carcinoma or dysplasia (75 of 149; 50%), but similar to patients having adenocarcinoma of the esophagus or esophagogastric junction without demonstrable Barrett esophagus (16 of 22; 73%). Our findings suggest that most adenocarcinomas of the esophagus or esophagogastric junction are Barrett carcinomas, rather than gastric cardiac cancers or other types of esophageal adenocarcinoma; most Barrett adenocarcinomas occur in short segments of Barrett esophagus, which may be difficult to detect at endoscopy; and white men with Barrett esophagus may constitute a clinically identifiable at-risk group suitable for surveillance.

摘要

食管或食管胃交界腺癌患者中Barrett食管的患病率及特征尚不确定。我们研究了61例连续的食管胃切除术腺癌标本,并对其进行了广泛的组织病理学检查。64%的病例(61例中的39例)发现有Barrett食管,但在术前接受内镜活检的Barrett相关癌患者中,只有38%被诊断出来(34例中的13例)。伴有腺癌的Barrett食管的中位长度为5厘米(范围1厘米至12厘米),且以特殊类型(“特化”)的Barrett黏膜为主(39例中的35例;90%)。Barrett腺癌集中在食管胃交界上方2厘米±0.3厘米的食管远端。与胃腺癌病例(69例中的21例;30%)以及无癌或发育异常的Barrett患者(149例中的75例;50%)相比,Barrett腺癌患者中白人男性占显著优势(39例中的34例;87%),但与无明显Barrett食管的食管或食管胃交界腺癌患者相似(22例中的16例;73%)。我们的研究结果表明,大多数食管或食管胃交界腺癌是Barrett癌,而非胃贲门癌或其他类型的食管腺癌;大多数Barrett腺癌发生在Barrett食管的短节段中,在内镜检查时可能难以检测到;患有Barrett食管的白人男性可能构成一个临床上可识别的高危群体,适合进行监测。

相似文献

1
Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction.食管或食管胃交界腺癌患者中Barrett食管的患病率及特征
Hum Pathol. 1988 Aug;19(8):942-8. doi: 10.1016/s0046-8177(88)80010-8.
2
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus.食管胃交界腺癌与巴雷特食管
Gastroenterology. 1995 Nov;109(5):1541-6. doi: 10.1016/0016-5085(95)90642-8.
3
Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction.巴雷特食管以及食管和胃食管交界腺癌
J Thorac Cardiovasc Surg. 1991 Jul;102(1):36-41; discussion 41-2.
4
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.远端食管和食管胃交界部癌发生的二分法:肠型与贲门型黏膜相关型腺癌。
Mod Pathol. 2011 Sep;24(9):1177-90. doi: 10.1038/modpathol.2011.77. Epub 2011 May 13.
5
p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.巴雷特食管、食管腺癌及食管胃交界腺癌中的p53和p21(WAF1/CIP1/SDI1)基因产物
Hum Pathol. 1996 Nov;27(11):1211-20. doi: 10.1016/s0046-8177(96)90317-2.
6
Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa.有和没有巴雷特黏膜的远端食管-胃食管交界腺癌患者的临床和组织学特征及生存率比较
Arch Surg. 2005 Jun;140(6):570-4; discussion 574-5. doi: 10.1001/archsurg.140.6.570.
7
Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.食管胃交界部小腺癌:与肠化生及发育异常的关联
Am J Gastroenterol. 2002 Jun;97(6):1375-80. doi: 10.1111/j.1572-0241.2002.05669.x.
8
Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.远端食管癌和“贲门癌”主要是食管癌。
Am J Surg Pathol. 2007 Apr;31(4):569-75. doi: 10.1097/01.pas.0000213394.34451.d2.
9
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.食管及食管胃交界部的特殊肠化生、发育异常和癌症:患病率及临床数据。
Gastroenterology. 1999 Feb;116(2):277-85. doi: 10.1016/s0016-5085(99)70123-x.
10
Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.特殊型肠化生、巴雷特食管及胃食管交界腺癌的发病率和患病率趋势
World J Surg. 2003 Sep;27(9):999-1008; discussion 1006-8. doi: 10.1007/s00268-003-7052-2. Epub 2003 Aug 18.

引用本文的文献

1
Improving clinical outcomes of Barrett's esophagus with high dose proton pump inhibitors and cryoablation.提高 Barrett 食管临床疗效的高剂量质子泵抑制剂和冷冻消融治疗。
Ann Med. 2023 Dec;55(1):1256-1264. doi: 10.1080/07853890.2023.2191002.
2
Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog.在医院环境中使用便携式空气净化器减少气溶胶,减少临床积压。
Epidemiol Infect. 2023 Jan 18;151:e21. doi: 10.1017/S0950268823000092.
3
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance.
巴雷特食管和食管腺癌的流行病学:筛查和监测的意义。
Gastrointest Endosc Clin N Am. 2021 Jan;31(1):1-26. doi: 10.1016/j.giec.2020.08.001. Epub 2020 Oct 21.
4
Short-Segment Barrett's Esophagus and Adenocarcinoma.短节段巴雷特食管与腺癌
Gastroenterol Hepatol (N Y). 2006 Feb;2(2):134-139.
5
Past, present and future of Barrett's oesophagus.巴雷特食管的过去、现在与未来
Eur J Surg Oncol. 2017 Jul;43(7):1148-1160. doi: 10.1016/j.ejso.2017.02.004. Epub 2017 Feb 16.
6
Carcinogenesis of Barrett's esophagus: a review of the clinical literature.巴雷特食管的致癌作用:临床文献综述
Clin J Gastroenterol. 2013 Dec;6(6):399-414. doi: 10.1007/s12328-013-0412-z. Epub 2013 Aug 14.
7
Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma.食管黏膜下腺导管化生与炎症及食管腺癌相关。
Histopathology. 2015 Dec;67(6):771-82. doi: 10.1111/his.12707. Epub 2015 Jun 4.
8
Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China.中国河南地区食管腺癌及其与巴雷特食管的罕见关联
PLoS One. 2014 Oct 15;9(10):e110348. doi: 10.1371/journal.pone.0110348. eCollection 2014.
9
Improved biopsy accuracy in Barrett's esophagus with a transparent cap.使用透明帽提高巴雷特食管活检的准确性。
World J Gastroenterol. 2014 Apr 28;20(16):4718-22. doi: 10.3748/wjg.v20.i16.4718.
10
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.口服双膦酸盐与 Barrett 食管风险:美国退伍军人的病例对照分析。
Am J Gastroenterol. 2013 Oct;108(10):1576-83. doi: 10.1038/ajg.2013.222. Epub 2013 Jul 16.